SlideShare a Scribd company logo
DIFFERENTIAL LEUCOCYTE COUNT
TOTAL LEUCOCYTE COUNT
4000 – 11000 per cubic mm of blood
Neutrophils
• Neutrophils are also known as polymorphonuclear
leukocytes because the nucleus is multilobed( 1 to 6 lobes
are present)
• Small, fine granules present. Granules appear purple in
colour since it takes both stains equally.
• Diameter is 10-14 microns
• Amoeboid or phagocytic in nature
• Functions are
• Along with monocytes, neutrophils provide the first line
of defence against invading microorganisms
• Neutrophils move by diapedesis towards the site of
infection by means of chemotaxis[attraction by
chemicals released from infected area]
• At the site of infection neutrophils get adhered to
infected tissues and destroy them by phagocytosis.
PHAGOCYTOSIS
Eosinophil
 Eosinophils have coarse or larger granules in the cytoplasm,
stain pink or red with eosin
 Nucleus is bilobed and spectacle shaped. Rarely trilobed
also
 Diameter 10-14 microns
 Functions
• Eosinophils are weak phagocytes.
• Eosinophils, act against parasitic infections
• Along with mast cells and basophils, they participate in
allergic reactions like asthma.
• They are responsible for detoxification, disintegration
and removal of foreign substances.
Basophils
• Basophils also have coarse granules in the cytoplasm and stain
purple blue
• Nucleus is bilobed
• Diameter is 8-10 microns
• Functions are
• They play an important role in healing processes
• They help initiate the inflammatory process at sites of
injury.
• Both mast cells and basophils liberate heparin, histamine,
bradykinin, serotonin.
• The mast cells and basophils play an important role in
some types of allergic reactions [hypersensitivity reaction ]
MONOCYTES
• They are the largest of the white blood cells with
diameter of 14-16 microns
• The cytoplasm is clear without granules
• The nucleus is round, oval, horse shoe shaped, bean
shaped or kidney shaped.
• The nucleus is placed either in the centre or pushed to
one side and a large amount of cytoplasm is seen
• Functions:
• They function mainly as phagocytic (engulfing) cells.
They are important in the long-term clean up of
debris in an area of injury.
• They are precursors of tissue macrophages.
• They act by secreting certain substances like
interleukin, colony stimulating factors, platelet
activating factors etc.
LYMPHOCYTES
• have large single nuclei that occupy almost whole of
the cells.
• Nucleus is oval or round shaped .
• A rim of cytoplasm may or may not be present.
I. Depending upon the function, lymphocytes are
classified in to two categories;
i. T lymphocytes concerned with cellular
immunity
ii. B lymphocytes concerned with humoral
immunity
II. Depending on the size, the lymphocytes are
divided in to two types;
i. Large lymphocytes are younger cells with a
diameter 10-12 microns
ii. Small lymphocytes are older cells with a
diameter of 7-10 microns
PLATELETS (THROMBOCYTES)
• are minute discs 1 to 4 micrometres in diameter.
• The normal concentration of
platelets in the blood is
between 150,000 and 300,000
per microliter
• They do not have nuclei and
cannot reproduce.
• The platelet membrane
contains large amounts of
phospholipids that activate
multiple stages in the blood-
clotting process
• On its surface is a coat of
glycoproteins
• It has a half-life in the blood of
8 to 12 days
HEMOSTASIS
• Means prevention of
blood loss or simply
Stoppage of bleeding.
• Whenever a vessel is
severed or ruptured,
haemostasis is achieved
by a series of reactions.
It occurs in three stages:
1. Vascular constriction
2. Formation of a
platelet plug
3. Formation of a
blood clot as a result
of blood coagulation
VASOCONSTRICTION
• Immediately after injury, blood vessels constricts and
decreases the loss of blood from the damaged portion
• When the blood vessel is cut, endothelium get
damaged and collagen is exposed.
• The platelets get adhered to this collagen and
activates platelets
• Activated platelets secrete serotonin and other
vasoconstrictor substances
• The adherence of platelets to collagen is accelerated
by von Willebrand factor.
FORMATION OF PLATELET PLUG
• The platelets get adhered to the collagen of
ruptured blood vessel and secrete ADP and
Thromboxane A2
• These two substances attract more and more
platelets which aggregate together
• This leads to the formation of a loose temporary
platelet plug, which closes the injured part of the
vessel and prevents further blood loss
• The platelet aggregation is accelerated by platelet
activating factor or PAF
Blood Coagulation
 Coagulation is the process in which blood loses its fluidity
and becomes a jelly like mass few minutes after it is shed
out or collected in a container.
 It occurs through a series of reactions due to activation of a
group of substances called clotting factors.
 Proenzymes must be activated in to enzymes which is
carried out by enzyme cascade reactions.
 Enzyme cascade refers to process that occurs through a
series of steps, each step initiating the next, until final step
is reached.
 The clotting factors are;
THE CLOTTING MECHANISM
STEP I
STEP II
STEP III
Three essential steps:
1. Formation of prothrombin activator: In
response to rupture of the vessel or damage
to the blood itself, prothrombin activator is
formed by a complex cascade of chemical
reactions occurs in the blood involving blood
coagulation factors .
2. Conversion of prothrombin into thrombin: It is
catalysed by the prothrombin activator
3. Conversion of fibrinogen to fibrin: The
thrombin acts as an enzyme to convert
fibrinogen into fibrin fibers that enmesh
platelets, blood cells, and plasma to form the
clot.
STAGE 1: FORMATION OF PROTHROMBIN
ACTIVATOR:
Prothrombin activator is generally considered to be
formed in two ways,
(1) by the extrinsic pathway that begins with trauma
to the vascular wall and surrounding tissues and
initiated by clotting factors released in damaged
vessels (tissue factor or thromboplastin) and
perivascular tissues - 15 seconds
(2) by the intrinsic pathway that begins in the blood
itself. uses only clotting factors found inside the
blood itself (plasma, platelets) 3- 6 seconds
INTRINSIC PATHWAY
INTRINSIC PATHWAY
 In this, the formation of prothrombin activator is initiated by
platelets within the blood itself
 Sequence of events in intrinsic pathway:
 During the injury, the blood vessel is ruptured. The
endothelium is damaged and collagen beneath the
endothelium is exposed.
 When platelets comes in contact with collagen of
damaged blood vessel, it gets activated and release
phospholipids.
 Now factor XII comes in contact with collagen, and is
converted to its activated form XIIa in the presence of
kallikrein and high molecular weight kinogen.
 The activated factor XIIa converts factor XI in to activated
XIa in the presence of kinogen
 The activated factor XIa converts factor IX in the presence
of factor IV(calcium) to its activated form IXa.
 Activated factor IXa activates factor X in the presence of
factor VIII and calcium to activated factor Xa
 Now the activated factor Xa reacts with platelet
phospholipid and factor V to form prothrombin
activator. This need the presence of calcium ions.
 Factor V is also activated by positive feedback effect of
thrombin.
EXTRINSIC PATHWAY
EXTRINSIC PATHWAY
 In this, the formation of prothrombin activator is initiated
by the tissue thromboplastin which is formed from the
injured tissues
 Sequence of events in extrinsic pathway are as follows:
i. The damaged tissues release factor III i.e. tissue
thromboplastin. The tissue thromboplastin contains
proteins, phospholipids and glycoprotein, which act
as proteolytic enzymes.
ii. The glycoprotein and phospholipid components of
thromboplastin converts factor X in to activated
factor Xa, in the presence of factor VII
iii. The activated Xa reacts with factor V and phospholipid
component of tissue thromboplastin to form
prothrombin activator. This reaction requires the
presence of calcium ions
STAGE 2: CONVERSION OF PROTHROMBIN IN TO THROMBIN
i. Prothrombin activator that is formed in the intrinsic
and extrinsic pathways convert prothrombin in to
thrombin in the presence of calcium ions.
ii. Once formed, thrombin initiates the formation of
more thrombin molecules. The initially formed
thrombin activates factor V. Factor V in turn
accelerates formation of both extrinsic and intrinsic
prothrombin activator which converts prothrombin
to thrombin
STAGE 3: CONVERSION OF FIBRINOGEN IN TO FIBRIN
 The final stage of blood clotting involves the conversion of
fibrinogen in to fibrin by thrombin
 Sequence of events are
i. Thrombin convert fibrinogen in to activated
fibrinogen called fibrin monomer
ii. Fibrin monomer polymerizes with other monomer
molecules and form loosely arranged strands of fibrin
iii. Later these loose strands are modified in to dense
and tight fibrin threads by fibrin stabilizing factor i.e.
factor XIII in the presence of calcium ions. All the
tight fibrin threads are aggregated to form a
meshwork of stable clot.
ANTICOAGULANTS
• Dicoumarol and coumadin block the activity of vitamin K,
which is necessary for synthesis of many of the clotting
factors by the liver.
• Heparin activates a plasma protein called antithrombin III,
which, in turn, inactivates thrombin and several of the other
clotting factors.
• Because calcium is an important clotting cofactor, calcium
chelators such as EDTA, oxalate, and citrate are used to
prevent stored blood from clotting.
• Various thrombolytic agents like tissue plasminogen
activator (tPA) are also available that promote dissolution of
the fibrin clot after it is formed. These agents promote the
formation of plasmin from plasminogen that enzymatically
attacks the clot, turning it into soluble peptides.
BLEEDING DISORDERS
HEMOPHILIA
• Sex linked inherited blood disorder
• Cause is lack of prothrombin activator due to deficiency of
clotting factors either factor VIII, IX, or XI .
• Based on it, classified into three types;
1. Hemophilia A or classic hemophilia due to deficiency of
factor VIII
2. Hemophilia B or Christmas disease due to deficiency of
factor IX
3. Hemophilia C due to deficiency of factor XI
• Characterized by prolonged clotting time; so even a mild trauma
like tooth extraction or bruising due to falls may result in excess
bleeding which can lead to death
• Males are affected ;females are carriers
PURPURA
Disorders characterized by prolonged bleeding time
Result in spontaneous bleeding under the skin from ruptured
capillaries
Thus causes appearance of small tiny haemorrhagic spots called
purpuric spot.
Classified into different types ;
1. Thrombocytopenic purpura (due to deficiency of platelets),
2. Thrombasthenic purpura (due to structural or functional
abnormality of platelets)
3. Idiopathic thrombocytopenic purpura.
Bleeding time
• The time interval from oozing of blood after a cut or
injury till arrest of bleeding
• Determined by duke’s method using bloating paper or
filter paper
• Normal duration is 3-6 minutes
• It is prolonged in purpura
TESTS FOR CLOTTING
Clotting time
• The time interval from oozing of blood after a cut or
injury till the formation of clot
• Determined by capillary tube method
• Normal duration is 3-8 minutes
• It is prolonged in hemophilia
Prothrombin Time / PTT
• The time taken by blood to clot after adding tissue
thromboplastin to it.
• It indicates the total quantity of prothrombin present in the
blood
• Normal duration is about 12 seconds
• It is normal in haemophilia. It is prolonged in deficiency or
prothrombin and other clotting factors like I,V,VII & X
EDEMA
• Swelling caused by excessive accumulation of fluid in tissues.
• Types of edema:
1. Intracellular edema
• is the accumulation of fluid inside the cell.
• It occurs due to malnutrition, poor metabolism or
inflammation of tissues.
2. Extracellular edema
• is the accumulation of fluid outside the cell.
• It occurs because of abnormal leakage of fluid from
capillaries in to interstitial space and obstruction of
lymphatics.
• It occurs in conditions like heart failure, renal disease,
decreased amount of plasma proteins, lymphatic
obstruction, increased endothelial permeability.
 Extracellular oedema can be of two types: Pitting and non-
pitting oedema
 Pitting edema
• In this type of edema, when the edemated area is pressed
with the finger, the displacement of fluid occurs producing a
depression or pit. The pit is disappeared after removal of
finger when the fluid flows back to the area.
• It occurs when the interstitial fluid volume increases. When
the volume increases, the semisolid nature of interstitial fluid
becomes more fluid type and flow freely in to tissue spaces.
 Non pitting edema
• In this type of edema, edemated area is hard and a pit is not
formed by pressing.
• Edema develops due to either swelling of the cells or clotting
of interstitial fluid in the presence of fibrinogen.

More Related Content

Similar to blood 1.pdf

Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
Pandian M
 
Lecture 11 & 12 Clot
Lecture 11 & 12  ClotLecture 11 & 12  Clot
Lecture 11 & 12 ClotMBBS IMS MSU
 
HEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptxHEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptx
YogeshAgrawal67
 
PC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdfPC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdf
RAMDAS BHAT
 
Coagulants and anticoagulants ppt
Coagulants and anticoagulants pptCoagulants and anticoagulants ppt
Coagulants and anticoagulants ppt
Rashmin Kulabkar
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
HEMOSTASIS.pptx
HEMOSTASIS.pptxHEMOSTASIS.pptx
HEMOSTASIS.pptx
SYED ALI AFRIN
 
Introduction to Hemostasis (Prevention of Blood Loss)
Introduction to Hemostasis (Prevention of Blood Loss)Introduction to Hemostasis (Prevention of Blood Loss)
Introduction to Hemostasis (Prevention of Blood Loss)
Aisha Olanrewaju
 
7. Coagulation of blood.ppt
7. Coagulation of blood.ppt7. Coagulation of blood.ppt
7. Coagulation of blood.ppt
lovekeshSingh12
 
Mechanism of Blood Coagulation
Mechanism of Blood Coagulation Mechanism of Blood Coagulation
Mechanism of Blood Coagulation
Sathish Rajamani
 
Hemostasis basic information
Hemostasis basic informationHemostasis basic information
Hemostasis basic information
Mbabazi Theos
 
5. Haematology
5. Haematology5. Haematology
5. Haematology
Mirza Anwar Baig
 
Hemostasis magdi sasi 2018 physiology limu
Hemostasis   magdi sasi 2018 physiology limuHemostasis   magdi sasi 2018 physiology limu
Hemostasis magdi sasi 2018 physiology limu
cardilogy
 
Coagulation of Blood
Coagulation of BloodCoagulation of Blood
Coagulation of Blood
Balraj Shukla
 
platelets & hemostasis.pptx
platelets & hemostasis.pptxplatelets & hemostasis.pptx
platelets & hemostasis.pptx
RenuYadav3305
 
Homeostasis.pptx
Homeostasis.pptxHomeostasis.pptx
Homeostasis.pptx
DrAmitJoshi9
 
Blood coagulation
Blood coagulationBlood coagulation
Blood coagulation
suma priyanka
 
6.platelets (1)
6.platelets (1)6.platelets (1)
6.platelets (1)
mariaidrees3
 
Hemostasis and coagulation faiz khan
Hemostasis and coagulation faiz khanHemostasis and coagulation faiz khan
Hemostasis and coagulation faiz khan
Khan Faiz
 
Blood coagulation cascade
Blood coagulation cascadeBlood coagulation cascade
Blood coagulation cascade
Bangaluru
 

Similar to blood 1.pdf (20)

Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
Hemostasis and coagulation of blood For M.Sc & Basic Medical Students by Pand...
 
Lecture 11 & 12 Clot
Lecture 11 & 12  ClotLecture 11 & 12  Clot
Lecture 11 & 12 Clot
 
HEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptxHEMOSTASIS & COAGULATION.pptx
HEMOSTASIS & COAGULATION.pptx
 
PC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdfPC of Blood and Blood forming agents.pdf
PC of Blood and Blood forming agents.pdf
 
Coagulants and anticoagulants ppt
Coagulants and anticoagulants pptCoagulants and anticoagulants ppt
Coagulants and anticoagulants ppt
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
HEMOSTASIS.pptx
HEMOSTASIS.pptxHEMOSTASIS.pptx
HEMOSTASIS.pptx
 
Introduction to Hemostasis (Prevention of Blood Loss)
Introduction to Hemostasis (Prevention of Blood Loss)Introduction to Hemostasis (Prevention of Blood Loss)
Introduction to Hemostasis (Prevention of Blood Loss)
 
7. Coagulation of blood.ppt
7. Coagulation of blood.ppt7. Coagulation of blood.ppt
7. Coagulation of blood.ppt
 
Mechanism of Blood Coagulation
Mechanism of Blood Coagulation Mechanism of Blood Coagulation
Mechanism of Blood Coagulation
 
Hemostasis basic information
Hemostasis basic informationHemostasis basic information
Hemostasis basic information
 
5. Haematology
5. Haematology5. Haematology
5. Haematology
 
Hemostasis magdi sasi 2018 physiology limu
Hemostasis   magdi sasi 2018 physiology limuHemostasis   magdi sasi 2018 physiology limu
Hemostasis magdi sasi 2018 physiology limu
 
Coagulation of Blood
Coagulation of BloodCoagulation of Blood
Coagulation of Blood
 
platelets & hemostasis.pptx
platelets & hemostasis.pptxplatelets & hemostasis.pptx
platelets & hemostasis.pptx
 
Homeostasis.pptx
Homeostasis.pptxHomeostasis.pptx
Homeostasis.pptx
 
Blood coagulation
Blood coagulationBlood coagulation
Blood coagulation
 
6.platelets (1)
6.platelets (1)6.platelets (1)
6.platelets (1)
 
Hemostasis and coagulation faiz khan
Hemostasis and coagulation faiz khanHemostasis and coagulation faiz khan
Hemostasis and coagulation faiz khan
 
Blood coagulation cascade
Blood coagulation cascadeBlood coagulation cascade
Blood coagulation cascade
 

More from DanjaarDasan

Handicapped ir differently abledkkooooii
Handicapped ir differently abledkkooooiiHandicapped ir differently abledkkooooii
Handicapped ir differently abledkkooooii
DanjaarDasan
 
sleepdisorder-140319141111-phpapp02 (1).pptx
sleepdisorder-140319141111-phpapp02 (1).pptxsleepdisorder-140319141111-phpapp02 (1).pptx
sleepdisorder-140319141111-phpapp02 (1).pptx
DanjaarDasan
 
criticalthinkinginnursingprocess-160308074152 (1).pdf
criticalthinkinginnursingprocess-160308074152 (1).pdfcriticalthinkinginnursingprocess-160308074152 (1).pdf
criticalthinkinginnursingprocess-160308074152 (1).pdf
DanjaarDasan
 
sleepdisorder-140319141111-phpapp02.pdf
sleepdisorder-140319141111-phpapp02.pdfsleepdisorder-140319141111-phpapp02.pdf
sleepdisorder-140319141111-phpapp02.pdf
DanjaarDasan
 
Presentation (4).pptx
Presentation (4).pptxPresentation (4).pptx
Presentation (4).pptx
DanjaarDasan
 
Presentation (2).pptx
Presentation (2).pptxPresentation (2).pptx
Presentation (2).pptx
DanjaarDasan
 
disasterppt-110926211357-phpapp01 (1).pdf
disasterppt-110926211357-phpapp01 (1).pdfdisasterppt-110926211357-phpapp01 (1).pdf
disasterppt-110926211357-phpapp01 (1).pdf
DanjaarDasan
 
MBR516OB04.pdf
MBR516OB04.pdfMBR516OB04.pdf
MBR516OB04.pdf
DanjaarDasan
 
careofbed-riddenpatient-220430131051 (1).pdf
careofbed-riddenpatient-220430131051 (1).pdfcareofbed-riddenpatient-220430131051 (1).pdf
careofbed-riddenpatient-220430131051 (1).pdf
DanjaarDasan
 
physiologyandfunctionsofskin-171225052733 (1).pdf
physiologyandfunctionsofskin-171225052733 (1).pdfphysiologyandfunctionsofskin-171225052733 (1).pdf
physiologyandfunctionsofskin-171225052733 (1).pdf
DanjaarDasan
 
biomedicalwastemanagement-160723173740 (1).pdf
biomedicalwastemanagement-160723173740 (1).pdfbiomedicalwastemanagement-160723173740 (1).pdf
biomedicalwastemanagement-160723173740 (1).pdf
DanjaarDasan
 
Special senses.pdf
Special senses.pdfSpecial senses.pdf
Special senses.pdf
DanjaarDasan
 
endocrine system.pdf
endocrine system.pdfendocrine system.pdf
endocrine system.pdf
DanjaarDasan
 
general physiology.pdf
general physiology.pdfgeneral physiology.pdf
general physiology.pdf
DanjaarDasan
 
respiration notes.pdf
respiration notes.pdfrespiration notes.pdf
respiration notes.pdf
DanjaarDasan
 
excretion pdf.pdf
excretion pdf.pdfexcretion pdf.pdf
excretion pdf.pdf
DanjaarDasan
 
Handicapped or differently abled (1).pdf
Handicapped or differently abled (1).pdfHandicapped or differently abled (1).pdf
Handicapped or differently abled (1).pdf
DanjaarDasan
 

More from DanjaarDasan (17)

Handicapped ir differently abledkkooooii
Handicapped ir differently abledkkooooiiHandicapped ir differently abledkkooooii
Handicapped ir differently abledkkooooii
 
sleepdisorder-140319141111-phpapp02 (1).pptx
sleepdisorder-140319141111-phpapp02 (1).pptxsleepdisorder-140319141111-phpapp02 (1).pptx
sleepdisorder-140319141111-phpapp02 (1).pptx
 
criticalthinkinginnursingprocess-160308074152 (1).pdf
criticalthinkinginnursingprocess-160308074152 (1).pdfcriticalthinkinginnursingprocess-160308074152 (1).pdf
criticalthinkinginnursingprocess-160308074152 (1).pdf
 
sleepdisorder-140319141111-phpapp02.pdf
sleepdisorder-140319141111-phpapp02.pdfsleepdisorder-140319141111-phpapp02.pdf
sleepdisorder-140319141111-phpapp02.pdf
 
Presentation (4).pptx
Presentation (4).pptxPresentation (4).pptx
Presentation (4).pptx
 
Presentation (2).pptx
Presentation (2).pptxPresentation (2).pptx
Presentation (2).pptx
 
disasterppt-110926211357-phpapp01 (1).pdf
disasterppt-110926211357-phpapp01 (1).pdfdisasterppt-110926211357-phpapp01 (1).pdf
disasterppt-110926211357-phpapp01 (1).pdf
 
MBR516OB04.pdf
MBR516OB04.pdfMBR516OB04.pdf
MBR516OB04.pdf
 
careofbed-riddenpatient-220430131051 (1).pdf
careofbed-riddenpatient-220430131051 (1).pdfcareofbed-riddenpatient-220430131051 (1).pdf
careofbed-riddenpatient-220430131051 (1).pdf
 
physiologyandfunctionsofskin-171225052733 (1).pdf
physiologyandfunctionsofskin-171225052733 (1).pdfphysiologyandfunctionsofskin-171225052733 (1).pdf
physiologyandfunctionsofskin-171225052733 (1).pdf
 
biomedicalwastemanagement-160723173740 (1).pdf
biomedicalwastemanagement-160723173740 (1).pdfbiomedicalwastemanagement-160723173740 (1).pdf
biomedicalwastemanagement-160723173740 (1).pdf
 
Special senses.pdf
Special senses.pdfSpecial senses.pdf
Special senses.pdf
 
endocrine system.pdf
endocrine system.pdfendocrine system.pdf
endocrine system.pdf
 
general physiology.pdf
general physiology.pdfgeneral physiology.pdf
general physiology.pdf
 
respiration notes.pdf
respiration notes.pdfrespiration notes.pdf
respiration notes.pdf
 
excretion pdf.pdf
excretion pdf.pdfexcretion pdf.pdf
excretion pdf.pdf
 
Handicapped or differently abled (1).pdf
Handicapped or differently abled (1).pdfHandicapped or differently abled (1).pdf
Handicapped or differently abled (1).pdf
 

Recently uploaded

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 

Recently uploaded (20)

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 

blood 1.pdf

  • 1.
  • 2. DIFFERENTIAL LEUCOCYTE COUNT TOTAL LEUCOCYTE COUNT 4000 – 11000 per cubic mm of blood
  • 3.
  • 4.
  • 5. Neutrophils • Neutrophils are also known as polymorphonuclear leukocytes because the nucleus is multilobed( 1 to 6 lobes are present) • Small, fine granules present. Granules appear purple in colour since it takes both stains equally. • Diameter is 10-14 microns • Amoeboid or phagocytic in nature • Functions are • Along with monocytes, neutrophils provide the first line of defence against invading microorganisms • Neutrophils move by diapedesis towards the site of infection by means of chemotaxis[attraction by chemicals released from infected area] • At the site of infection neutrophils get adhered to infected tissues and destroy them by phagocytosis.
  • 7. Eosinophil  Eosinophils have coarse or larger granules in the cytoplasm, stain pink or red with eosin  Nucleus is bilobed and spectacle shaped. Rarely trilobed also  Diameter 10-14 microns  Functions • Eosinophils are weak phagocytes. • Eosinophils, act against parasitic infections • Along with mast cells and basophils, they participate in allergic reactions like asthma. • They are responsible for detoxification, disintegration and removal of foreign substances.
  • 8. Basophils • Basophils also have coarse granules in the cytoplasm and stain purple blue • Nucleus is bilobed • Diameter is 8-10 microns • Functions are • They play an important role in healing processes • They help initiate the inflammatory process at sites of injury. • Both mast cells and basophils liberate heparin, histamine, bradykinin, serotonin. • The mast cells and basophils play an important role in some types of allergic reactions [hypersensitivity reaction ]
  • 9. MONOCYTES • They are the largest of the white blood cells with diameter of 14-16 microns • The cytoplasm is clear without granules • The nucleus is round, oval, horse shoe shaped, bean shaped or kidney shaped. • The nucleus is placed either in the centre or pushed to one side and a large amount of cytoplasm is seen • Functions: • They function mainly as phagocytic (engulfing) cells. They are important in the long-term clean up of debris in an area of injury. • They are precursors of tissue macrophages. • They act by secreting certain substances like interleukin, colony stimulating factors, platelet activating factors etc.
  • 10. LYMPHOCYTES • have large single nuclei that occupy almost whole of the cells. • Nucleus is oval or round shaped . • A rim of cytoplasm may or may not be present. I. Depending upon the function, lymphocytes are classified in to two categories; i. T lymphocytes concerned with cellular immunity ii. B lymphocytes concerned with humoral immunity II. Depending on the size, the lymphocytes are divided in to two types; i. Large lymphocytes are younger cells with a diameter 10-12 microns ii. Small lymphocytes are older cells with a diameter of 7-10 microns
  • 11.
  • 12. PLATELETS (THROMBOCYTES) • are minute discs 1 to 4 micrometres in diameter. • The normal concentration of platelets in the blood is between 150,000 and 300,000 per microliter • They do not have nuclei and cannot reproduce. • The platelet membrane contains large amounts of phospholipids that activate multiple stages in the blood- clotting process • On its surface is a coat of glycoproteins • It has a half-life in the blood of 8 to 12 days
  • 13. HEMOSTASIS • Means prevention of blood loss or simply Stoppage of bleeding. • Whenever a vessel is severed or ruptured, haemostasis is achieved by a series of reactions. It occurs in three stages: 1. Vascular constriction 2. Formation of a platelet plug 3. Formation of a blood clot as a result of blood coagulation
  • 14. VASOCONSTRICTION • Immediately after injury, blood vessels constricts and decreases the loss of blood from the damaged portion • When the blood vessel is cut, endothelium get damaged and collagen is exposed. • The platelets get adhered to this collagen and activates platelets • Activated platelets secrete serotonin and other vasoconstrictor substances • The adherence of platelets to collagen is accelerated by von Willebrand factor.
  • 15. FORMATION OF PLATELET PLUG • The platelets get adhered to the collagen of ruptured blood vessel and secrete ADP and Thromboxane A2 • These two substances attract more and more platelets which aggregate together • This leads to the formation of a loose temporary platelet plug, which closes the injured part of the vessel and prevents further blood loss • The platelet aggregation is accelerated by platelet activating factor or PAF
  • 17.  Coagulation is the process in which blood loses its fluidity and becomes a jelly like mass few minutes after it is shed out or collected in a container.  It occurs through a series of reactions due to activation of a group of substances called clotting factors.  Proenzymes must be activated in to enzymes which is carried out by enzyme cascade reactions.  Enzyme cascade refers to process that occurs through a series of steps, each step initiating the next, until final step is reached.  The clotting factors are;
  • 18.
  • 19. THE CLOTTING MECHANISM STEP I STEP II STEP III
  • 20. Three essential steps: 1. Formation of prothrombin activator: In response to rupture of the vessel or damage to the blood itself, prothrombin activator is formed by a complex cascade of chemical reactions occurs in the blood involving blood coagulation factors . 2. Conversion of prothrombin into thrombin: It is catalysed by the prothrombin activator 3. Conversion of fibrinogen to fibrin: The thrombin acts as an enzyme to convert fibrinogen into fibrin fibers that enmesh platelets, blood cells, and plasma to form the clot.
  • 21. STAGE 1: FORMATION OF PROTHROMBIN ACTIVATOR: Prothrombin activator is generally considered to be formed in two ways, (1) by the extrinsic pathway that begins with trauma to the vascular wall and surrounding tissues and initiated by clotting factors released in damaged vessels (tissue factor or thromboplastin) and perivascular tissues - 15 seconds (2) by the intrinsic pathway that begins in the blood itself. uses only clotting factors found inside the blood itself (plasma, platelets) 3- 6 seconds
  • 23. INTRINSIC PATHWAY  In this, the formation of prothrombin activator is initiated by platelets within the blood itself  Sequence of events in intrinsic pathway:  During the injury, the blood vessel is ruptured. The endothelium is damaged and collagen beneath the endothelium is exposed.  When platelets comes in contact with collagen of damaged blood vessel, it gets activated and release phospholipids.  Now factor XII comes in contact with collagen, and is converted to its activated form XIIa in the presence of kallikrein and high molecular weight kinogen.  The activated factor XIIa converts factor XI in to activated XIa in the presence of kinogen  The activated factor XIa converts factor IX in the presence of factor IV(calcium) to its activated form IXa.
  • 24.  Activated factor IXa activates factor X in the presence of factor VIII and calcium to activated factor Xa  Now the activated factor Xa reacts with platelet phospholipid and factor V to form prothrombin activator. This need the presence of calcium ions.  Factor V is also activated by positive feedback effect of thrombin.
  • 26. EXTRINSIC PATHWAY  In this, the formation of prothrombin activator is initiated by the tissue thromboplastin which is formed from the injured tissues  Sequence of events in extrinsic pathway are as follows: i. The damaged tissues release factor III i.e. tissue thromboplastin. The tissue thromboplastin contains proteins, phospholipids and glycoprotein, which act as proteolytic enzymes. ii. The glycoprotein and phospholipid components of thromboplastin converts factor X in to activated factor Xa, in the presence of factor VII iii. The activated Xa reacts with factor V and phospholipid component of tissue thromboplastin to form prothrombin activator. This reaction requires the presence of calcium ions
  • 27. STAGE 2: CONVERSION OF PROTHROMBIN IN TO THROMBIN i. Prothrombin activator that is formed in the intrinsic and extrinsic pathways convert prothrombin in to thrombin in the presence of calcium ions. ii. Once formed, thrombin initiates the formation of more thrombin molecules. The initially formed thrombin activates factor V. Factor V in turn accelerates formation of both extrinsic and intrinsic prothrombin activator which converts prothrombin to thrombin
  • 28. STAGE 3: CONVERSION OF FIBRINOGEN IN TO FIBRIN  The final stage of blood clotting involves the conversion of fibrinogen in to fibrin by thrombin  Sequence of events are i. Thrombin convert fibrinogen in to activated fibrinogen called fibrin monomer ii. Fibrin monomer polymerizes with other monomer molecules and form loosely arranged strands of fibrin iii. Later these loose strands are modified in to dense and tight fibrin threads by fibrin stabilizing factor i.e. factor XIII in the presence of calcium ions. All the tight fibrin threads are aggregated to form a meshwork of stable clot.
  • 29. ANTICOAGULANTS • Dicoumarol and coumadin block the activity of vitamin K, which is necessary for synthesis of many of the clotting factors by the liver. • Heparin activates a plasma protein called antithrombin III, which, in turn, inactivates thrombin and several of the other clotting factors. • Because calcium is an important clotting cofactor, calcium chelators such as EDTA, oxalate, and citrate are used to prevent stored blood from clotting. • Various thrombolytic agents like tissue plasminogen activator (tPA) are also available that promote dissolution of the fibrin clot after it is formed. These agents promote the formation of plasmin from plasminogen that enzymatically attacks the clot, turning it into soluble peptides.
  • 30. BLEEDING DISORDERS HEMOPHILIA • Sex linked inherited blood disorder • Cause is lack of prothrombin activator due to deficiency of clotting factors either factor VIII, IX, or XI . • Based on it, classified into three types; 1. Hemophilia A or classic hemophilia due to deficiency of factor VIII 2. Hemophilia B or Christmas disease due to deficiency of factor IX 3. Hemophilia C due to deficiency of factor XI • Characterized by prolonged clotting time; so even a mild trauma like tooth extraction or bruising due to falls may result in excess bleeding which can lead to death • Males are affected ;females are carriers
  • 31. PURPURA Disorders characterized by prolonged bleeding time Result in spontaneous bleeding under the skin from ruptured capillaries Thus causes appearance of small tiny haemorrhagic spots called purpuric spot. Classified into different types ; 1. Thrombocytopenic purpura (due to deficiency of platelets), 2. Thrombasthenic purpura (due to structural or functional abnormality of platelets) 3. Idiopathic thrombocytopenic purpura.
  • 32. Bleeding time • The time interval from oozing of blood after a cut or injury till arrest of bleeding • Determined by duke’s method using bloating paper or filter paper • Normal duration is 3-6 minutes • It is prolonged in purpura TESTS FOR CLOTTING Clotting time • The time interval from oozing of blood after a cut or injury till the formation of clot • Determined by capillary tube method • Normal duration is 3-8 minutes • It is prolonged in hemophilia
  • 33. Prothrombin Time / PTT • The time taken by blood to clot after adding tissue thromboplastin to it. • It indicates the total quantity of prothrombin present in the blood • Normal duration is about 12 seconds • It is normal in haemophilia. It is prolonged in deficiency or prothrombin and other clotting factors like I,V,VII & X
  • 34. EDEMA • Swelling caused by excessive accumulation of fluid in tissues. • Types of edema: 1. Intracellular edema • is the accumulation of fluid inside the cell. • It occurs due to malnutrition, poor metabolism or inflammation of tissues. 2. Extracellular edema • is the accumulation of fluid outside the cell. • It occurs because of abnormal leakage of fluid from capillaries in to interstitial space and obstruction of lymphatics. • It occurs in conditions like heart failure, renal disease, decreased amount of plasma proteins, lymphatic obstruction, increased endothelial permeability.
  • 35.  Extracellular oedema can be of two types: Pitting and non- pitting oedema  Pitting edema • In this type of edema, when the edemated area is pressed with the finger, the displacement of fluid occurs producing a depression or pit. The pit is disappeared after removal of finger when the fluid flows back to the area. • It occurs when the interstitial fluid volume increases. When the volume increases, the semisolid nature of interstitial fluid becomes more fluid type and flow freely in to tissue spaces.  Non pitting edema • In this type of edema, edemated area is hard and a pit is not formed by pressing. • Edema develops due to either swelling of the cells or clotting of interstitial fluid in the presence of fibrinogen.